tiprankstipranks
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market
Holding FULC?
Track your performance easily

Fulcrum Therapeutics (FULC) Ownership - Who Owns Fulcrum Therapeutics?

484 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
May 09, 2024
xxxxxxxxxxxxx
$1831
Mar 05, 2024
Alex Sapir
President & Ceo,director
xxxxxxxxxxxxx
$491702

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$325641
Sep 30, 2024
xxxxxxxxxxxxx
$2394780
Sep 30, 2024
xxxxxxxxxxxxx
$36517883

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,229,099Institution18.96%41,939,306
3,109,704Insider5.77%12,749,786
2,981,637Institution5.53%12,224,712
2,634,728Institution4.88%10,802,385
2,430,692Institution4.51%9,965,837
1,825,492Institution3.38%7,484,517
1,059,860Institution1.96%4,345,426
696,175Institution1.29%2,854,318
670,807Institution1.24%2,750,309
656,866Institution1.22%2,693,151

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,634,728Institution4.88%10,802,385
1,825,492Institution3.38%7,484,517
1,059,860Institution1.96%4,345,426
696,175Institution1.29%2,854,318
656,866Institution1.22%2,693,151
523,219Institution0.97%2,145,198
311,266Institution0.58%1,276,191
306,538Institution0.57%1,256,806
197,676Institution0.37%810,472
140,480Institution0.26%575,968

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,852,255Institution3.43%7,131,182
1,687,690Institution3.13%6,919,529
782,473Institution1.45%3,012,521
331,137Institution0.61%1,357,662
293,171Institution0.54%1,128,708
245,467Institution0.46%1,006,415
209,910Institution0.39%852,235
147,144Institution0.27%597,405
144,004Institution0.27%590,416
142,739Institution0.26%579,520

FAQ

Who Owns Fulcrum Therapeutics (FULC)?
Currently, no data Available
What percentage of Fulcrum Therapeutics (FULC) stock is held by institutional investors?
Currently, no data Available
What percentage of Fulcrum Therapeutics (FULC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Fulcrum Therapeutics (FULC)?
Peter Kolchinsky owns the most shares of Fulcrum Therapeutics (FULC).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis